These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
378 related items for PubMed ID: 31784574
1. Pelvic lymph node dissection and its extent on survival benefit in prostate cancer patients with a risk of lymph node invasion >5%: a propensity score matching analysis from SEER database. Chen J, Wang Z, Zhao J, Zhu S, Sun G, Liu J, Zhang H, Zhang X, Shen P, Shi M, Zeng H. Sci Rep; 2019 Nov 29; 9(1):17985. PubMed ID: 31784574 [Abstract] [Full Text] [Related]
2. Extent of lymph node dissection improves survival in prostate cancer patients treated with radical prostatectomy without lymph node invasion. Preisser F, Bandini M, Marchioni M, Nazzani S, Tian Z, Pompe RS, Fossati N, Briganti A, Saad F, Shariat SF, Heinzer H, Huland H, Graefen M, Tilki D, Karakiewicz PI. Prostate; 2018 May 29; 78(6):469-475. PubMed ID: 29460290 [Abstract] [Full Text] [Related]
3. Pelvic lymph node dissection in prostate cancer. Briganti A, Blute ML, Eastham JH, Graefen M, Heidenreich A, Karnes JR, Montorsi F, Studer UE. Eur Urol; 2009 Jun 29; 55(6):1251-65. PubMed ID: 19297079 [Abstract] [Full Text] [Related]
4. Indication for and extension of pelvic lymph node dissection during robot-assisted radical prostatectomy: an analysis of five European institutions. Suardi N, Larcher A, Haese A, Ficarra V, Govorov A, Buffi NM, Walz J, Rocco B, Borghesi M, Steuber T, Pini G, Briganti A, Mottrie AM, Guazzoni G, Montorsi F, Pushkar D, Van Der Poel H, EAU Young Academic Urologists–Robotic Section. Eur Urol; 2014 Oct 29; 66(4):635-43. PubMed ID: 24411992 [Abstract] [Full Text] [Related]
5. Adherence to pelvic lymph node dissection recommendations according to the National Comprehensive Cancer Network pelvic lymph node dissection guideline and the D'Amico lymph node invasion risk stratification. Leyh-Bannurah SR, Budäus L, Zaffuto E, Pompe RS, Bandini M, Briganti A, Montorsi F, Schiffmann J, Shariat SF, Fisch M, Chun F, Huland H, Graefen M, Karakiewicz PI. Urol Oncol; 2018 Feb 29; 36(2):81.e17-81.e24. PubMed ID: 29248430 [Abstract] [Full Text] [Related]
6. A Head-to-head Comparison of Four Prognostic Models for Prediction of Lymph Node Invasion in African American and Caucasian Individuals. Bandini M, Marchioni M, Preisser F, Nazzani S, Tian Z, Fossati N, Gandaglia G, Shariat SF, Montorsi F, Saad F, Briganti A, Tilki D, Karakiewicz PI. Eur Urol Focus; 2019 May 29; 5(3):449-456. PubMed ID: 29249688 [Abstract] [Full Text] [Related]
7. Increasing rate of lymph node invasion in patients with prostate cancer treated with radical prostatectomy and lymph node dissection. Preisser F, Nazzani S, Bandini M, Marchioni M, Tian Z, Montorsi F, Saad F, Briganti A, Steuber T, Budäus L, Huland H, Graefen M, Tilki D, Karakiewicz PI. Urol Oncol; 2018 Aug 29; 36(8):365.e1-365.e7. PubMed ID: 29887241 [Abstract] [Full Text] [Related]
8. North American Population-Based Validation of the National Comprehensive Cancer Network Practice Guideline Recommendation of Pelvic Lymphadenectomy in Contemporary Prostate Cancer. Leyh-Bannurah SR, Budäus L, Pompe R, Zaffuto E, Briganti A, Abdollah F, Montorsi F, Schiffmann J, Menon M, Shariat SF, Fisch M, Chun F, Huland H, Graefen M, Karakiewicz PI. Prostate; 2017 Apr 29; 77(5):542-548. PubMed ID: 28093788 [Abstract] [Full Text] [Related]
10. Oncological Outcome After Radical Prostatectomy without Pelvic Lymph Node Dissection for Localized Prostate Cancer: Follow-up Results in a Single Institution. Tomisaki I, Ikuta H, Higashijima K, Onishi R, Minato A, Fujimoto N. Cancer Invest; 2019 Apr 29; 37(10):524-530. PubMed ID: 31597501 [Abstract] [Full Text] [Related]
11. First North American validation and head-to-head comparison of four preoperative nomograms for prediction of lymph node invasion before radical prostatectomy. Bandini M, Marchioni M, Pompe RS, Tian Z, Gandaglia G, Fossati N, Abdollah F, Graefen M, Montorsi F, Saad F, Shariat SF, Briganti A, Karakiewicz PI. BJU Int; 2018 Apr 29; 121(4):592-599. PubMed ID: 29124911 [Abstract] [Full Text] [Related]
12. Identifying the Candidates Who Will Benefit From Extended Pelvic Lymph Node Dissection at Radical Prostatectomy Among Patients With Prostate Cancer. Yang G, Xie J, Guo Y, Yuan J, Wang R, Guo C, Peng B, Yao X, Yang B. Front Oncol; 2021 Apr 29; 11():790183. PubMed ID: 35155191 [Abstract] [Full Text] [Related]
13. Effect of pelvic lymph node dissection and its extent on oncological outcomes in intermediate-risk prostate cancer patients: A multicenter study of the Turkish Uro-oncology Association. Izol V, Ok F, Aslan G, Akdogan B, Sozen S, Ozden E, Celik O, Muezzinoglu T, Turkeri L, Akdogan N, Baltaci S. Prostate; 2022 May 29; 82(7):763-771. PubMed ID: 35188993 [Abstract] [Full Text] [Related]
15. External validation of the updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection. Gacci M, Schiavina R, Lanciotti M, Masieri L, Serni S, Vagnoni V, Abdollah F, Carini M, Martorana G, Montorsi F. Urol Int; 2013 May 29; 90(3):277-82. PubMed ID: 23296120 [Abstract] [Full Text] [Related]
16. A population-based assessment of the National Comprehensive Cancer Network practice guideline indications for pelvic lymph node dissection at radical prostatectomy. Abdollah F, Schmitges J, Sun M, Shariat SF, Briganti A, Abdo A, Tian Z, Perrotte P, Montorsi F, Karakiewicz PI. BJU Int; 2012 Apr 29; 109(8):1177-82. PubMed ID: 21880105 [Abstract] [Full Text] [Related]
17. Current status of pelvic lymph node dissection in prostate cancer: the New York PLND nomogram. Kazzazi A, Djavan B. Can J Urol; 2011 Apr 29; 18(2):5585-91. PubMed ID: 21504645 [Abstract] [Full Text] [Related]